{"id":"https://openalex.org/W4362392879","doi":"https://doi.org/10.1158/1078-0432.22442678","title":"Supplementary Data from Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells","display_name":"Supplementary Data from Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362392879","doi":"https://doi.org/10.1158/1078-0432.22442678"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22442678","doi":"https://doi.org/10.1158/1078-0432.22442678","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22442678","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Synergistic_Effect_between_Erlotinib_and_MEK_Inhibitors_in_KRAS_Wild-Type_Human_Pancreatic_Cancer_Cells/22442678/1/files/39893570.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Synergistic_Effect_between_Erlotinib_and_MEK_Inhibitors_in_KRAS_Wild-Type_Human_Pancreatic_Cancer_Cells/22442678/1/files/39893570.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012318055","display_name":"Caroline H. Diep","orcid":"https://orcid.org/0000-0001-9011-6450","observed_orcids":["https://orcid.org/0000-0001-9011-6450"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline H. Diep","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105360654","display_name":"Rub\u00e9n M. Mu\u00f1oz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruben M. Munoz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101435935","display_name":"Ashish Kumar Choudhary","orcid":"https://orcid.org/0000-0001-5551-3821","observed_orcids":["https://orcid.org/0000-0001-5551-3821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashish Choudhary","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080900202","display_name":"Daniel D. Von Hoff","orcid":"https://orcid.org/0000-0003-4723-7681","observed_orcids":["https://orcid.org/0000-0003-4723-7681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel D. Von Hoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037894273","display_name":"Haiyong Han","orcid":"https://orcid.org/0000-0001-9031-9880","observed_orcids":["https://orcid.org/0000-0001-9031-9880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haiyong Han","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.04529999941587448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":1.0},{"id":"https://openalex.org/keywords/kras-wild-type","display_name":"KRAS wild-type","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9252378940582275},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8955250382423401},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6686332821846008},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49079379439353943},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.44782131910324097},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38933634757995605},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3558697998523712},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3496814966201782},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3282352089881897},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31510746479034424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29329341650009155},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.15347543358802795},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.141525000333786},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12060397863388062},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22442678","doi":"https://doi.org/10.1158/1078-0432.22442678","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22442678","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Synergistic_Effect_between_Erlotinib_and_MEK_Inhibitors_in_KRAS_Wild-Type_Human_Pancreatic_Cancer_Cells/22442678/1/files/39893570.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22442678","doi":"https://doi.org/10.1158/1078-0432.22442678","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22442678","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Synergistic_Effect_between_Erlotinib_and_MEK_Inhibitors_in_KRAS_Wild-Type_Human_Pancreatic_Cancer_Cells/22442678/1/files/39893570.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362392879.pdf","grobid_xml":"https://content.openalex.org/works/W4362392879.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361818132","https://openalex.org/W2124797061","https://openalex.org/W1803959510","https://openalex.org/W2051341131","https://openalex.org/W4393096833","https://openalex.org/W1918325854","https://openalex.org/W2211890826","https://openalex.org/W2052427664","https://openalex.org/W4362477945","https://openalex.org/W4402804805"],"abstract_inverted_index":{"Supplementary":[0,3],"Figures":[1],"S1-S9;":[2],"Tables":[4],"S1-S3.":[5]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}